Optimization and therapeutic activity of liposome-conjugated monoclonal antibodies against the ErbB family of receptor tyrosine kinases: First step in the development of therapeutic antibody/liposomal anticancer drug combinations

Optimization and therapeutic activity of liposome-conjugated monoclonal antibodies against the ErbB family of receptor tyrosine kinases: First step in the development of therapeutic antibody/liposomal anticancer drug combinations

10.2174/157018006778631884

Saved in:
Bibliographic Details
Main Authors: Chiu, G.N.C., Harasym, T.O., Tardi, P.G., Bally, M.B., Waterhouse, D.N.
Other Authors: PHARMACY
Format: Article
Published: 2014
Subjects:
Combination therapy
Liposomes
Therapeutic antibodies
Online Access:http://scholarbank.nus.edu.sg/handle/10635/106183
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-106183
record_format dspace
spelling sg-nus-scholar.10635-1061832015-01-16T12:26:23Z Optimization and therapeutic activity of liposome-conjugated monoclonal antibodies against the ErbB family of receptor tyrosine kinases: First step in the development of therapeutic antibody/liposomal anticancer drug combinations Chiu, G.N.C. Harasym, T.O. Tardi, P.G. Bally, M.B. Waterhouse, D.N. PHARMACY Combination therapy Liposomes Therapeutic antibodies 10.2174/157018006778631884 Letters in Drug Design and Discovery 3 10 704-713 2014-10-29T01:56:15Z 2014-10-29T01:56:15Z 2006-12 Article Chiu, G.N.C.,Harasym, T.O.,Tardi, P.G.,Bally, M.B.,Waterhouse, D.N. (2006-12). Optimization and therapeutic activity of liposome-conjugated monoclonal antibodies against the ErbB family of receptor tyrosine kinases: First step in the development of therapeutic antibody/liposomal anticancer drug combinations. Letters in Drug Design and Discovery 3 (10) : 704-713. ScholarBank@NUS Repository. <a href="https://doi.org/10.2174/157018006778631884" target="_blank">https://doi.org/10.2174/157018006778631884</a> 15701808 http://scholarbank.nus.edu.sg/handle/10635/106183 NOT_IN_WOS Scopus
institution National University of Singapore
building NUS Library
country Singapore
collection ScholarBank@NUS
topic Combination therapy
Liposomes
Therapeutic antibodies
spellingShingle Combination therapy
Liposomes
Therapeutic antibodies
Chiu, G.N.C.
Harasym, T.O.
Tardi, P.G.
Bally, M.B.
Waterhouse, D.N.
Optimization and therapeutic activity of liposome-conjugated monoclonal antibodies against the ErbB family of receptor tyrosine kinases: First step in the development of therapeutic antibody/liposomal anticancer drug combinations
description 10.2174/157018006778631884
author2 PHARMACY
author_facet PHARMACY
Chiu, G.N.C.
Harasym, T.O.
Tardi, P.G.
Bally, M.B.
Waterhouse, D.N.
format Article
author Chiu, G.N.C.
Harasym, T.O.
Tardi, P.G.
Bally, M.B.
Waterhouse, D.N.
author_sort Chiu, G.N.C.
title Optimization and therapeutic activity of liposome-conjugated monoclonal antibodies against the ErbB family of receptor tyrosine kinases: First step in the development of therapeutic antibody/liposomal anticancer drug combinations
title_short Optimization and therapeutic activity of liposome-conjugated monoclonal antibodies against the ErbB family of receptor tyrosine kinases: First step in the development of therapeutic antibody/liposomal anticancer drug combinations
title_full Optimization and therapeutic activity of liposome-conjugated monoclonal antibodies against the ErbB family of receptor tyrosine kinases: First step in the development of therapeutic antibody/liposomal anticancer drug combinations
title_fullStr Optimization and therapeutic activity of liposome-conjugated monoclonal antibodies against the ErbB family of receptor tyrosine kinases: First step in the development of therapeutic antibody/liposomal anticancer drug combinations
title_full_unstemmed Optimization and therapeutic activity of liposome-conjugated monoclonal antibodies against the ErbB family of receptor tyrosine kinases: First step in the development of therapeutic antibody/liposomal anticancer drug combinations
title_sort optimization and therapeutic activity of liposome-conjugated monoclonal antibodies against the erbb family of receptor tyrosine kinases: first step in the development of therapeutic antibody/liposomal anticancer drug combinations
publishDate 2014
url http://scholarbank.nus.edu.sg/handle/10635/106183
_version_ 1681093417724018688

Similar Items